Riskpilot← Back to searchSign inGet full accessDyrlægehuset Trige ApS
APSActiveCVR 40482075Smedebroen 9Veterinary activities · NACE 7500Est. 201911 employees
Revenue 2024
DKK 4,2M
+9% vs 2023
EBITDA margin
14.9%
+100% vs 2023
Equity ratio
19.7%
Financial strength
Net profit 2024
DKK 183K
+354% vs 2023
| Revenue | DKK 4,2M | +9% |
| EBITDA | DKK 626K | +100% |
| Net profit | DKK 183K | +354% |
| Total assets | DKK 2M | -21% |
| Equity | DKK 391K | +88% |
| Employees | 11 | — |
Legal name
Dyrlægehuset Trige ApS
CVR number
40482075
Legal form
Anpartsselskab
NACE code
7500 · Veterinary activities
Founded
1. maj 2019
Share capital
DKK 51.000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive dyrlægeklinik samt anden hermed beslægtet virksomhed.
Address
Smedebroen 9
Email
trige@dlhuset.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 1.866 | 3.936 | 3.744 | 3.456 | 3.856 | 4.195 |
| Staff expenses | -1.694 | -2.750 | -3.024 | -2.806 | -3.543 | -3.569 |
| EBITDA | 172 | 1.186 | 719 | 649 | 313 | 626 |
| Depreciation & amort. | 102 | -167 | -209 | -269 | -328 | -328 |
| EBIT | 70 | 1.019 | 511 | 381 | -15 | 298 |
| Net financials | -80 | -84 | -61 | -109 | -77 | -59 |
| Profit before tax | -10 | 934 | 449 | 272 | -92 | 239 |
| Tax | -2 | 207 | 100 | 62 | -20 | 56 |
| Net profit | -8 | 728 | 350 | 210 | -72 | 183 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 1.903 | 2.408 | 2.408 | 2.928 | 2.496 | 1.984 |
| Equity | 43 | 771 | 220 | 431 | 208 | 391 |
| Long-term debt | 1.315 | 31 | 32 | 683 | 205 | 0 |
| Short-term debt | 545 | 1.496 | 2.022 | 1.658 | 1.947 | 1.455 |
| Total debt | 1.860 | 1.527 | 2.054 | 2.341 | 2.151 | 1.455 |
EBITDA margin
14.9%
This company
15.8%
Market median
-6% vs market
20192024
Equity ratio
19.7%
This company
38.2%
Market median
-48% vs market
20192024
Return on equity
46.8%
This company
18.4%
Market median
+154% vs market
20192024
Net profit margin
4.4%
This company
8.1%
Market median
-46% vs market
20192024
Asset turnover
2.11×
This company
1.12×
Market median
+88% vs market
20192024
Debt / equity
4.07×
This company
0.62×
Market median
-556% vs market
20192024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-05-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SE Management | Management | 2019 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
T.B. Jessen Holding ApS | Company | 33.3% | 33.3% | 2019 |
SERG Holding ApS | Company | 33.3% | 33.3% | 2019 |
GMG Holding ApS | Company | 33.3% | 33.3% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
GMG Holding ApS
Dyrlægehuset Trige ApS Board members of Dyrlægehuset Trige ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Svend Erik Ramskov Garbus | Management | 0 companies |